HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sang-We Kim Selected Research

Alanine Transaminase (SGPT)

3/2024Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study.
11/2017Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study.
1/2016Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sang-We Kim Research Topics

Disease

122Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024 - 07/2002
62Neoplasms (Cancer)
03/2024 - 12/2003
34Disease Progression
03/2024 - 12/2003
17Neoplasm Metastasis (Metastasis)
10/2023 - 07/2002
15Lung Neoplasms (Lung Cancer)
12/2023 - 07/2012
9Adenocarcinoma
07/2023 - 11/2008
9Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2023 - 10/2007
9Adenocarcinoma of Lung
01/2021 - 04/2012
7Neutropenia
03/2024 - 10/2007
7Brain Neoplasms (Brain Tumor)
05/2023 - 09/2009
7Exanthema (Rash)
01/2022 - 05/2012
5Diarrhea
12/2023 - 12/2012
5Nausea
12/2023 - 01/2014
4Dyspnea (Shortness of Breath)
12/2023 - 12/2003
4Vomiting
12/2023 - 01/2014
3Fatigue
07/2023 - 04/2012
3Stomach Neoplasms (Stomach Cancer)
06/2021 - 05/2013
3Pneumonia (Pneumonitis)
01/2020 - 12/2003
3Breast Neoplasms (Breast Cancer)
01/2019 - 02/2005
3Lymphoma (Lymphomas)
01/2016 - 11/2003
3Acne Vulgaris
01/2016 - 01/2004
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2011 - 08/2010
3Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2011 - 08/2002
2Pain (Aches)
12/2023 - 12/2003
2Hemoptysis
12/2023 - 12/2003
2Colorectal Neoplasms (Colorectal Cancer)
07/2023 - 01/2022
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 01/2019
2Sarcoma (Soft Tissue Sarcoma)
09/2020 - 09/2015
2Epilepsy (Aura)
04/2017 - 04/2016
2Renal Insufficiency (Renal Failure)
01/2016 - 04/2012
2Interstitial Lung Diseases (Interstitial Lung Disease)
04/2012 - 02/2010
2Multiple Myeloma
02/2011 - 04/2010
2Pathologic Constriction (Stenosis)
07/2009 - 12/2003

Drug/Important Bio-Agent (IBA)

43ErbB Receptors (EGF Receptor)IBA
02/2024 - 01/2004
33Tyrosine Kinase InhibitorsIBA
01/2024 - 09/2009
23Gefitinib (Iressa)FDA Link
06/2023 - 01/2004
21PlatinumIBA
03/2024 - 11/2007
20osimertinibIBA
01/2024 - 04/2015
15Pemetrexed (MTA)FDA Link
11/2023 - 06/2011
14Cisplatin (Platino)FDA LinkGeneric
11/2023 - 07/2003
12Erlotinib Hydrochloride (CP 358,774)FDA Link
06/2019 - 09/2009
10durvalumabIBA
03/2024 - 10/2019
10AfatinibIBA
01/2022 - 05/2012
9NivolumabIBA
01/2024 - 10/2017
8Immune Checkpoint InhibitorsIBA
12/2023 - 01/2020
7Carboplatin (JM8)FDA LinkGeneric
11/2023 - 02/2005
6GemcitabineFDA Link
04/2012 - 02/2006
5Docetaxel (Taxotere)FDA Link
03/2024 - 02/2010
5lazertinibIBA
02/2024 - 12/2019
5CrizotinibIBA
05/2023 - 09/2015
5Anaplastic Lymphoma KinaseIBA
01/2023 - 09/2015
5Proteins (Proteins, Gene)FDA Link
07/2022 - 05/2006
55- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA
07/2022 - 03/2016
5Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 08/2003
4Biomarkers (Surrogate Marker)IBA
02/2024 - 09/2017
4pembrolizumabIBA
12/2023 - 01/2019
4Bevacizumab (Avastin)FDA Link
10/2023 - 06/2011
4Monoclonal AntibodiesIBA
07/2023 - 02/2017
4IpilimumabIBA
01/2023 - 11/2016
4B7-H1 AntigenIBA
01/2023 - 11/2019
4brigatinibIBA
12/2022 - 08/2017
4Etoposide (VP 16)FDA LinkGeneric
01/2019 - 02/2011
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2011 - 02/2005
3tremelimumabIBA
03/2024 - 01/2023
3Alanine Transaminase (SGPT)IBA
03/2024 - 01/2016
3amivantamab-vmjwIBA
11/2023 - 10/2021
3ceritinibIBA
01/2023 - 01/2017
3LigandsIBA
08/2021 - 07/2012
3belotecanIBA
01/2021 - 10/2007
3EnzymesIBA
01/2020 - 01/2016
3Doxorubicin (Adriamycin)FDA LinkGeneric
02/2011 - 12/2003
2atezolizumabIBA
03/2024 - 10/2023
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
03/2024 - 11/2017
2Circulating Tumor DNAIBA
11/2023 - 01/2020
21- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA
01/2023 - 01/2020
2alectinibIBA
12/2022 - 01/2019
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 04/2017
2CamptothecinIBA
01/2021 - 01/2010
2Protein Glutamine gamma Glutamyltransferase 2IBA
01/2020 - 01/2019
2Peptides (Polypeptides)IBA
01/2020 - 01/2019
2Irinotecan (Camptosar)FDA LinkGeneric
01/2019 - 12/2011
2DNA (Deoxyribonucleic Acid)IBA
12/2017 - 01/2016
2nimotuzumabIBA
08/2017 - 02/2017
2Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2016 - 12/2003
2Lamivudine (Epivir)FDA Link
01/2016 - 12/2003
2Ondansetron (Zofran)FDA LinkGeneric
12/2015 - 01/2014
2Dexamethasone (Maxidex)FDA LinkGeneric
12/2015 - 02/2011
2Vincristine (Oncovin)FDA LinkGeneric
02/2011 - 09/2010
2Rituximab (Mabthera)FDA Link
09/2010 - 08/2010
2Epidermal Growth Factor (EGF)IBA
09/2009 - 01/2004
2Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
06/2005 - 02/2005

Therapy/Procedure

71Drug Therapy (Chemotherapy)
03/2024 - 07/2002
50Therapeutics
03/2024 - 11/2008
15Radiotherapy
01/2024 - 07/2002
9Immunotherapy
03/2024 - 02/2019
5Adjuvant Chemotherapy
11/2023 - 07/2002
5Stem Cell Transplantation
02/2011 - 08/2002
4Chemoradiotherapy
03/2024 - 05/2005
2Aftercare (After-Treatment)
09/2009 - 11/2008
2Stents
07/2009 - 12/2003